A new systematic review highlights three critical findings that should inform HIV eye care strategies. First, teleretinal screening’s 97.73% specificity ensures that positive test results are highly reliable, allowing clinicians to confidently recommend ophthalmologic follow-up without unnecessary false alarms. Second, the technology demonstrates particular utility for detecting cytomegalovirus retinitis in patients with the lowest CD4 counts—those at highest risk for vision loss—making early identification feasible even in resource-constrained environments.
Third, and perhaps most importantly, teleretinal screening represents a scalable, cost-effective solution for regions lacking adequate numbers of eye specialists. By enabling remote diagnostic capabilities, this approach can systematically identify patients requiring urgent interventions, ultimately preventing irreversible blindness.
These findings suggest teleretinal screening should be integrated into comprehensive HIV care protocols, particularly in underserved settings.
Was this article helpful?
